FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Ciro Gallo

Research Profile

Procedures

Antineoplastic Combined Chemotherapy Protocols

Disorders

Concepts & Ideas

Chemicals & Drugs

Geographic Areas

Italy

Co-author Network

Publications

TOP 3
Antonio Daponte; Ciro Gallo; Antonio Maria Grimaldi; Secondo Lastoria; Luigi Maiorino; Bruno Massidda; Nicola Mozzillo; Giuseppe Palmieri; Antonella Petrillo; Simona Signoriello; Ester Simeone; Pasquale Aprea; Paolo A Ascierto; Gerardo Botti; Corrado Caracò; Ernesta Cavalcanti; Giuseppe Comella; Antonio Cossu
Phase III randomized study of fotemustine and dacarbazine versus dacarbazine with or without interferon-α in advanced malignant melanoma.
Massimo Di Maio; Morena Fasano; Adolfo Favaretto; Ronald Feld; Raffaella Felletti; Vittorio Fregoni; Ciro Gallo; Vittorio Gebbia; Giovenzio Genestreti; Cesare Gridelli; Natasha B Leighl; Paolo Maione; Gianfranco Mancuso; Alessandro Morabito; Floriana Morgillo; Francesco Perrone; Alberto Ravaioli; Ferdinando Riccardi; Antonio Rossi; Salvatore Siena; Simona Signoriello; Mario Spatafora; Ming Sound Tsao; Rafal Wierzbicki; Yasmin Alam; Roberto Bianco; Charles Butts; Fortunato Ciardiello; Saverio Cinieri
Quality of life analysis of TORCH, a randomized trial testing first-line erlotinib followed by second-line cisplatin/gemcitabine chemotherapy in advanced non-small-cell lung cancer.
Luca De Nicola; Maurizio Postorino; Carmine Zoccali; Silvio Borrelli; Paolo Chiodini; Giuseppe Conte; Giorgio Fuiano; Ciro Gallo; Carmela Iodice; Roberto Minutolo; Felice Nappi
The effect of increasing age on the prognosis of non-dialysis patients with chronic kidney disease receiving stable nephrology care.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Ciro Gallo (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Antonio Daponte; Ciro Gallo; Antonio Maria Grimaldi; Secondo Lastoria; Luigi Maiorino; Bruno Massidda; Nicola Mozzillo; Giuseppe Palmieri; Antonella Petrillo; Simona Signoriello; Ester Simeone; Pasquale Aprea; Paolo A Ascierto; Gerardo Botti; Corrado Caracò; Ernesta Cavalcanti; Giuseppe Comella; Antonio Cossu
Phase III randomized study of fotemustine and dacarbazine versus dacarbazine with or without interferon-α in advanced malignant melanoma.
Journal of translational medicine 2013;11():38.
2012: Massimo Di Maio; Morena Fasano; Adolfo Favaretto; Ronald Feld; Raffaella Felletti; Vittorio Fregoni; Ciro Gallo; Vittorio Gebbia; Giovenzio Genestreti; Cesare Gridelli; Natasha B Leighl; Paolo Maione; Gianfranco Mancuso; Alessandro Morabito; Floriana Morgillo; Francesco Perrone; Alberto Ravaioli; Ferdinando Riccardi; Antonio Rossi; Salvatore Siena; Simona Signoriello; Mario Spatafora; Ming Sound Tsao; Rafal Wierzbicki; Yasmin Alam; Roberto Bianco; Charles Butts; Fortunato Ciardiello; Saverio Cinieri
Quality of life analysis of TORCH, a randomized trial testing first-line erlotinib followed by second-line cisplatin/gemcitabine chemotherapy in advanced non-small-cell lung cancer.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2012;7(12):1830-44.
2012: Luca De Nicola; Maurizio Postorino; Carmine Zoccali; Silvio Borrelli; Paolo Chiodini; Giuseppe Conte; Giorgio Fuiano; Ciro Gallo; Carmela Iodice; Roberto Minutolo; Felice Nappi
The effect of increasing age on the prognosis of non-dialysis patients with chronic kidney disease receiving stable nephrology care.
Kidney international 2012;82(4):482-8.
2012: Massimo Di Maio; Adolfo Favaretto; Ciro Gallo; Vittorio Gebbia; Pasqualina Giordano; Santi Barbera; Domenico Bilancia; Francesco Carrozza; Anna Ceribelli; Silvio Cigolari; R Costanzo; Bruno Daniele; Gennaro Daniele; Alfonso Illiano; Paolo Maione; Alessandro Morabito; Francesco Perrone; Francovito Piantedosi; Elena Piazza; Maria Carmela Piccirillo; Sergio Federico Robbiati; Gaetano Rocco; Antonio Rossi; C Sandomenico; Simona Signoriello; Cesare Gridelli
Prognostic impact of education level of patients with advanced non-small cell lung cancer enrolled in clinical trials.
Lung cancer (Amsterdam, Netherlands) 2012;76(3):457-64.
2012: Ferdinando C Sasso; Simona Signoriello; Roberto Torella; Ornella Carbonara; Paolo Chiodini; Giuseppe Conte; Luca De Nicola; Ciro Gallo; Raffaele Marfella; Roberto Minutolo; Rodolfo Nasti; Teresa Salvatore
High cardiovascular risk in patients with Type 2 diabetic nephropathy: the predictive role of albuminuria and glomerular filtration rate. The NID-2 Prospective Cohort Study.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2012;27(6):2269-74.
2012: Antonio Rossi; Robin Michael Rudd; Epaminondas Samantas; Taro Shibata; Dimosthenis Vasilios Skarlos; Tomohide Tamura; Paolo Chiodini; Massimo Di Maio; Martin Früh; Ciro Gallo; Cesare Gridelli; Olga Martelli; Hiroaki Okamoto; Francesco Perrone; Wendi Qian; Siow Ming Lee
Carboplatin- or cisplatin-based chemotherapy in first-line treatment of small-cell lung cancer: the COCIS meta-analysis of individual patient data.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2012;30(14):1692-8.
2012: Simona Signoriello; Mario Visconti; Annalisa Annunziata; Fulvio Calise; Vincenzo Castaldo; Paolo Chiodini; Bruno Daniele; Ilario De Sio; Giovan Giuseppe Di Costanzo; Massimo Di Maio; Mario Fusco; Ciro Gallo; Nicola Lama; Rosario Lanzetta; Giampiero Marone; Graziano Olivieri; Francesco Perrone; Guido Piai; Giuseppe Signoriello; Giovanni B Gaeta
Survival after locoregional treatments for hepatocellular carcinoma: a cohort study in real-world patients.
TheScientificWorldJournal 2012;2012():564706.
2012: Cesare Gridelli; Rosario Vincenzo Iaffaioli; Luciano Isa; Paolo Maione; Alessandro Morabito; Francesco Perrone; Maria Carmela Piccirillo; Gaetano Rocco; Antonio Rossi; Simona Signoriello; Aldo Vecchione; Santi Barbera; Emiddio Barletta; Anna Ceribelli; Ermelinda De Maio; Massimo Di Maio; ADOLFO FAVARETTO; Virginio Filipazzi; Ciro Gallo; Teresa Gamucci
Phase I-II trial of gemcitabine-based first-line chemotherapies for small cell lung cancer in elderly patients with performance status 0-2: the G-STEP trial.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2012;7(1):233-42.
2011: Luca De Nicola; Biagio R Di Iorio; Ciro Gallo; Vincenzo Giancaspro; Roberto Minutolo; Domenico Santoro; Carmine Zoccali; Cataldo Abaterusso; Silvio Borrelli; Paolo Chiodini; Bruno Cianciaruso; Giuseppe Conte
Prognosis of CKD patients receiving outpatient nephrology care in Italy.
Clinical journal of the American Society of Nephrology : CJASN 2011;6(10):2421-8.
2011: Sandro Pignata; Carmela Pisano; Alberto Ravaioli; Vanda Salutari; Antonella Savarese; Laura Scaltriti; Giovanni Scambia; Paolo Scollo; Roberto Sorio; Stefano Tamberi; Maria Rosaria Valerio; Enrico Aitini; Alba Brandes; Enrico Breda; Pietro Del Medico; Massimo Di Maio; Antonio Febbraro; Gabriella Ferrandina; Antonella Ferro; Luigi Frigerio; Ciro Gallo; Vittorio Gebbia; Stefano Greggi; Francesco Legge; Alessandra Vernaglia Lombardi; Domenica Lorusso; Alessandro Morabito; Pietro Musso; Donato Natale; Francesco Perrone
Carboplatin plus paclitaxel versus carboplatin plus pegylated liposomal doxorubicin as first-line treatment for patients with ovarian cancer: the MITO-2 randomized phase III trial.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2011;29(27):3628-35.
2011: Francesco Nuzzo; Alessandro Morabito; Adriano Gravina; Francesca Di Rella; Gabriella Landi; Carmen Pacilio; Vincenzo Labonia; Emanuela Rossi; Ermelinda De Maio; Maria Carmela Piccirillo; Giuseppe D'Aiuto; Renato Thomas; Massimo Rinaldo; Gerardo Botti; Maurizio Di Bonito; Massimo Di Maio; Ciro Gallo; Francesco Perrone; Andrea de Matteis
Effects on quality of life of weekly docetaxel-based chemotherapy in patients with locally advanced or metastatic breast cancer: results of a single-centre randomized phase 3 trial.
BMC cancer 2011;11():75.
2010: Giuseppe Colucci; Roberto Labianca; Francesco Di Costanzo; Vittorio Gebbia; Giacomo Cartenì; Bruno Massidda; Elisa Dapretto; Luigi Manzione; Elena Piazza; Mirella Sannicolò; Marco Ciaparrone; Luigi Cavanna; Francesco Giuliani; Evaristo Maiello; Antonio Testa; Paolo Pederzoli; Massimo Falconi; Ciro Gallo; Massimo Di Maio; Francesco Perrone
Randomized phase III trial of gemcitabine plus cisplatin compared with single-agent gemcitabine as first-line treatment of patients with advanced pancreatic cancer: the GIP-1 study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2010;28(10):1645-51.
2010: Massimo Di Maio; Nicola Lama; Alessandro Morabito; Egbert F Smit; Vassilis Georgoulias; Koji Takeda; Elisabeth Quoix; Dora Hatzidaki; Floris M Wachters; Vittorio Gebbia; Chun-Ming Tsai; Carlos Camps; Wolfgang Schuette; Paolo Chiodini; Maria Carmela Piccirillo; Francesco Perrone; Ciro Gallo; Cesare Gridelli
Clinical assessment of patients with advanced non-small-cell lung cancer eligible for second-line chemotherapy: a prognostic score from individual data of nine randomised trials.
European journal of cancer (Oxford, England : 1990) 2010;46(4):735-43.
2010: Massimo Di Maio; Ciro Gallo; Ermelinda De Maio; Alessandro Morabito; Maria Carmela Piccirillo; Cesare Gridelli; Francesco Perrone
Methodological aspects of lung cancer clinical trials in the era of targeted agents.
Lung cancer (Amsterdam, Netherlands) 2010;67(2):127-35.
2010: Gianfranco De Feo; Simona Signoriello; Jane C Bryce; Antonia Del Giudice; Giuliana Canzanella; Federika Crudele; Fiorella Romano; Giovanni de Matteis; Manuela Florio; Fabiano Falasconi; Alfonso Savio; Pasqualina Giordano; Gennaro Daniele; Mario Iaccarino; Maria Carmela Piccirillo; Massimo Di Maio; Alessandro Morabito; Ciro Gallo; Francesco Perrone
Time spent for activation of non-profit studies in oncology in Italy.
PloS one 2010;5(7):e11864.
2009: Carmela Pisano; Alessandro Morabito; Roberto Sorio; Enrico Breda; Rossella Lauria; Vittorio Gebbia; Laura Scaltriti; Simona Scalone; Vittorina Zagonel; Stefano Greggi; Gerardo Beneduce; Simona Losito; Ciro Gallo; Massimo Di Maio; Valeria Forestieri; Sandro Pignata
A phase II study of capecitabine in the treatment of ovarian cancer resistant or refractory to platinum therapy: a multicentre Italian trial in ovarian cancer (MITO-6) trial.
Cancer chemotherapy and pharmacology 2009;64(5):1021-7.
2009: Emanuela Rossi; Alessandro Morabito; Francesca Di Rella; Giuseppe Esposito; Adriano Gravina; Vincenzo Labonia; Gabriella Landi; Francesco Nuzzo; Carmen Pacilio; Ermelinda De Maio; Massimo Di Maio; Maria Carmela Piccirillo; Gianfranco De Feo; Giuseppe D'Aiuto; Gerardo Botti; Paolo Chiodini; Ciro Gallo; Francesco Perrone; Andrea de Matteis
Endocrine effects of adjuvant letrozole compared with tamoxifen in hormone-responsive postmenopausal patients with early breast cancer: the HOBOE trial.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009;27(19):3192-7.
2009: Massimo Di Maio; Paolo Chiodini; Vassilis Georgoulias; Dora Hatzidaki; Koji Takeda; Floris M Wachters; Vittorio Gebbia; Egbert F Smit; Alessandro Morabito; Ciro Gallo; Francesco Perrone; Cesare Gridelli
Meta-analysis of single-agent chemotherapy compared with combination chemotherapy as second-line treatment of advanced non-small-cell lung cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009;27(11):1836-43.
2008: Fausta Catapano; Paolo Chiodini; Luca De Nicola; Roberto Minutolo; Pasquale Zamboli; Ciro Gallo; Giuseppe Conte
Antiproteinuric response to dual blockade of the renin-angiotensin system in primary glomerulonephritis: meta-analysis and metaregression.
American journal of kidney diseases : the official journal of the National Kidney Foundation 2008;52(3):475-85.
2008: Nicola Lama; Ciro Gallo
Re: Visualizing length of survival in time-to-event studies: a complement to Kaplan-Meier plots.
Journal of the National Cancer Institute 2008;100(16):1188; author reply 1188-9.
2008: Francesco Nuzzo; Alessandro Morabito; Ermelinda De Maio; Francesca Di Rella; Adriano Gravina; Vincenzo Labonia; Gabriella Landi; Carmen Pacilio; Maria Carmela Piccirillo; Emanuela Rossi; Giuseppe D'Aiuto; Renato Thomas; Stefania Gori; Mariantonietta Colozza; Sabino De Placido; Rossella Lauria; Giuseppe Signoriello; Ciro Gallo; Francesco Perrone; Andrea de Matteis
Weekly docetaxel versus CMF as adjuvant chemotherapy for elderly breast cancer patients: safety data from the multicentre phase 3 randomised ELDA trial.
Critical reviews in oncology/hematology 2008;66(2):171-80.
2008: Massimo Di Maio; Bruno Daniele; Sandro Pignata; Ciro Gallo; Ermelinda De Maio; Alessandro Morabito; Maria-Carmela Piccirillo; Francesco Perrone
Is human hepatocellular carcinoma a hormone-responsive tumor?
World journal of gastroenterology : WJG 2008;14(11):1682-9.
2008: Emanuela Rossi; Alessandro Morabito; Ermelinda De Maio; Francesca Di Rella; Giuseppe Esposito; Adriano Gravina; Vincenzo Labonia; Gabriella Landi; Francesco Nuzzo; Carmen Pacilio; Maria Carmela Piccirillo; Giuseppe D'Aiuto; Massimiliano D'Aiuto; Massimo Rinaldo; Gerardo Botti; Ciro Gallo; Francesco Perrone; Andrea de Matteis
Endocrine effects of adjuvant letrozole + triptorelin compared with tamoxifen + triptorelin in premenopausal patients with early breast cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(2):264-70.
2007: Alessandro Morabito; Maria Carmela Piccirillo; Katia Monaco; Carmen Pacilio; Francesco Nuzzo; Paolo Chiodini; Ciro Gallo; Andrea de Matteis; Francesco Perrone
First-line chemotherapy for HER-2 negative metastatic breast cancer patients who received anthracyclines as adjuvant treatment.
The oncologist 2007;12(11):1288-98.
2007: Cesare Gridelli; Paolo Maione; Alfonso Illiano; Francovito Piantedosi; ADOLFO FAVARETTO; alessandra bearz; Sergio Federico Robbiati; Virginio Filipazzi; Vito Lorusso; Francesco Carrozza; Rosario Vincenzo Iaffaioli; Luigi Manzione; Ciro Gallo; Alessandro Morabito; Francesco Perrone
Cisplatin plus gemcitabine or vinorelbine for elderly patients with advanced non small-cell lung cancer: the MILES-2P studies.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(29):4663-9.
2007: F Caruso; L Nastri; M Arienzo; Giuseppe Signoriello; C Picardi; C Mazza; U Caruso; Ciro Gallo
Association between threatened pre-term labour and periodontal disease: does a relationship exist? A matched case-control study.
Minerva stomatologica 2007;56(9):415-26.
2007: Sandro Pignata; Giovanni Scambia; Claudio Pisano; Enrico Breda; Massimo Di Maio; Stefano Greggi; Gabriella Ferrandina; Domenica Lorusso; V Zagonel; Antonio Febbraro; N Riva; V De Rosa; Ciro Gallo; Francesco Perrone
A multicentre phase II study of carboplatin plus pegylated liposomal doxorubicin as first-line chemotherapy for patients with advanced or recurrent endometrial carcinoma: the END-1 study of the MITO (Multicentre Italian Trials in Ovarian Cancer and Gynecologic Malignancies) group.
British journal of cancer 2007;96(11):1639-43.
2007: Cesare Gridelli; Ciro Gallo; Anna Ceribelli; Vittorio Gebbia; Teresa Gamucci; Fortunato Ciardiello; Francesco Carozza; ADOLFO FAVARETTO; Bruno Daniele; Domenico Galetta; Santi Barbera; Francesco Rosetti; Antonio Rossi; Paolo Maione; Francesco Cognetti; Antonio Testa; Massimo Di Maio; Alessandro Morabito; Francesco Perrone
Factorial phase III randomised trial of rofecoxib and prolonged constant infusion of gemcitabine in advanced non-small-cell lung cancer: the GEmcitabine-COxib in NSCLC (GECO) study.
The lancet oncology 2007;8(6):500-12.
2007: Massimo Di Maio; Francesco Perrone; Paolo Chiodini; Ciro Gallo; Carlos Camps; Wolfgang Schuette; Elisabeth Quoix; Chun-Ming Tsai; Cesare Gridelli
Individual patient data meta-analysis of docetaxel administered once every 3 weeks compared with once every week second-line treatment of advanced non-small-cell lung cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(11):1377-82.
2006: Massimo Di Maio; Ermelinda De Maio; Alessandro Morabito; Roberta D'Aniello; Gianfranco De Feo; Ciro Gallo; Francesco Perrone
Hormonal treatment of human hepatocellular carcinoma.
Annals of the New York Academy of Sciences 2006;1089():252-61.
2006: Sandro Pignata; Ciro Gallo; Bruno Daniele; Silvana Elba; Antonio Giorgio; Gaetano Capuano; Luigi E Adinolfi; Ilario De Sio; Francesco Izzo; Fabio Farinati; Carlo Del Naja; Maria Stanzione; Fabiana Castiglione; Giampiero Marone; Oreste Cuomo; Martina Felder; Giovanni B Gaeta; Ermelinda De Maio; Massimo Di Maio; Giuseppe Signoriello; Francesco Perrone
Characteristics at presentation and outcome of hepatocellular carcinoma (HCC) in the elderly. A study of the Cancer of the Liver Italian Program (CLIP).
Critical reviews in oncology/hematology 2006;59(3):243-9.
2006: Carmen Pacilio; Alessandro Morabito; Francesco Nuzzo; Adriano Gravina; Vincenzo Labonia; Gabriella Landi; Emanuela Rossi; Ermelinda De Maio; Massimo Di Maio; Giuseppe D'Aiuto; Gerardo Botti; N Normanno; P Chiodini; Ciro Gallo; Francesco Perrone; Andrea de Matteis
Is epirubicin effective in first-line chemotherapy of metastatic breast cancer (MBC) after an epirubicin-containing adjuvant treatment? A single centre phase III trial.
British journal of cancer 2006;94(9):1233-6.
2006: Ciro Gallo; Ermelinda De Maio; Massimo Di Maio; Giuseppe Signoriello; Bruno Daniele; Sandro Pignata; Annalisa Annunziata; Francesco Perrone
Tamoxifen is not effective in good prognosis patients with hepatocellular carcinoma.
BMC cancer 2006;6():196.
2005: Sabino De Placido; Massimo Lopez; Chiara Carlomagno; Giancarlo Paoletti; S Palazzo; Luigi Manzione; C Iannace; Giovanni Pietro Ianniello; Ferdinando De Vita; Corrado Ficorella; Antonio Farris; Giorgio Pistillucci; M Gemini; E Cortesi; Vincenzo Adamo; Nicola Gebbia; Sergio Palmeri; Ciro Gallo; Francesco Perrone; Giovanni Persico; Angelo Raffaele Bianco
Modulation of 5-fluorouracil as adjuvant systemic chemotherapy in colorectal cancer: the IGCS-COL multicentre, randomised, phase III study.
British journal of cancer 2005;93(8):896-904.
2005: Massimo Di Maio; Cesare Gridelli; Ciro Gallo; Frances A Shepherd; Francovito Piantedosi; Silvio Cigolari; Luigi Manzione; Alfonso Illiano; Santi Barbera; Sergio Federico Robbiati; Luciano Frontini; Elena Piazza; Giovanni Pietro Ianniello; Enzo Veltri; Federico Castiglione; Francesco Rosetti; Vittorio Gebbia; Lesley Seymour; Paolo Chiodini; Francesco Perrone
Chemotherapy-induced neutropenia and treatment efficacy in advanced non-small-cell lung cancer: a pooled analysis of three randomised trials.
The lancet oncology 2005;6(9):669-77.
2005: Luca De Nicola; Roberto Minutolo; Ciro Gallo; Carmine Zoccali; Bruno Cianciaruso; Marilena Conte; A Lupo; Giorgio Fuiano; Mario Gallucci; M Bonomini; Paolo Chiodini; Giuseppe Signoriello; Vincenzo Bellizzi; F Mallamaci; Felice Nappi; Giuseppe Conte
Management of hypertension in chronic kidney disease: the Italian multicentric study.
Journal of nephrology 2005;18(4):397-404.
2004: Cesare Gridelli; Ciro Gallo; Massimo Di Maio; Emiddio Barletta; Alfonso Illiano; Paolo Maione; Stefania Salvagni; Francovito Piantedosi; G Palazzolo; O Caffo; Anna Ceribelli; A Falcone; P Mazzanti; Luigi Brancaccio; M A Capuano; L Isa; Santi Barbera; Francesco Perrone
A randomised clinical trial of two docetaxel regimens (weekly vs 3 week) in the second-line treatment of non-small-cell lung cancer. The DISTAL 01 study.
British journal of cancer 2004;91(12):1996-2004.
2004: Ciro Gallo; Francesco Perrone
Clinical trial design in oncology: statistical power.
The lancet oncology 2004;5(12):760-1.
2004: Sabino De Placido; Giovanni Scambia; Giovanni Di Vagno; Emanuele Naglieri; Alessandra Vernaglia Lombardi; Rosalbino Biamonte; Marco Marinaccio; Giacomo Cartenì; Luigi Manzione; Antonio Febbraro; Andrea de Matteis; Gianpietro Gasparini; Maria Rosaria Valerio; Saverio Danese; Francesco Perrone; Rossella Lauria; Michele De Laurentiis; Stefano Greggi; Ciro Gallo; Sandro Pignata
Topotecan compared with no therapy after response to surgery and carboplatin/paclitaxel in patients with ovarian cancer: Multicenter Italian Trials in Ovarian Cancer (MITO-1) randomized study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2004;22(13):2635-42.
2004: Massimo Di Maio; Cesare Gridelli; Ciro Gallo; Luigi Manzione; Luigi Brancaccio; Santi Barbera; Sergio Federico Robbiati; Giovanni Pietro Ianniello; Francesco Ferraù; Elena Piazza; Luciano Frontini; Francesco Rosetti; Francesco Carrozza; alessandra bearz; M Spatafora; Vincenzo Adamo; L Isa; Rosario Vincenzo Iaffaioli; Enrico Di Salvo; Francesco Perrone
Prevalence and management of pain in Italian patients with advanced non-small-cell lung cancer.
British journal of cancer 2004;90(12):2288-96.
2003: Cesare Gridelli; Ciro Gallo; Frances A Shepherd; Alfonso Illiano; Francovito Piantedosi; Sergio Federico Robbiati; Luigi Manzione; Santi Barbera; Luciano Frontini; Enzo Veltri; Brian Findlay; Silvio Cigolari; Robert Myers; Giovanni Pietro Ianniello; Vittorio Gebbia; Giampietro Gasparini; Sergio Fava; Vera Hirsh; Andrea Bezjak; Lesley Seymour; Francesco Perrone
Gemcitabine plus vinorelbine compared with cisplatin plus vinorelbine or cisplatin plus gemcitabine for advanced non-small-cell lung cancer: a phase III trial of the Italian GEMVIN Investigators and the National Cancer Institute of Canada Clinical Trials Group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2003;21(16):3025-34.
2003: Francesco Perrone; Massimo Di Maio; Ermelinda De Maio; Paolo Maione; Alessandro Ottaiano; Matilde Pensabene; Giuseppe Di Lorenzo; Alessandra Vernaglia Lombardi; Giuseppe Signoriello; Ciro Gallo
Statistical design in phase II clinical trials and its application in breast cancer.
The lancet oncology 2003;4(5):305-11.
2003: Adolfo Ferro; Letizia Perillo Nucci; Fabrizia Ferro; Ciro Gallo
Long-term stability of skeletal Class III patients treated with splints, Class III elastics, and chincup.
American journal of orthodontics and dentofacial orthopedics : official publication of the American Association of Orthodontists, its constituent societies, and the American Board of Orthodontics 2003;123(4):423-34.
2003: Cesare Gridelli; Francesco Perrone; Ciro Gallo; Silvio Cigolari; Antonio Rossi; Francovito Piantedosi; Santi Barbera; Francesco Ferraù; Elena Piazza; Francesco Rosetti; Maurizia Clerici; Oscar Bertetto; Sergio Federico Robbiati; Luciano Frontini; Cosimo Sacco; Federico Castiglione; ADOLFO FAVARETTO; Silvia Novello; Maria Rita Migliorino; Giampietro Gasparini; Domenico Galetta; Rosario Vincenzo Iaffaioli; Vittorio Gebbia
Chemotherapy for elderly patients with advanced non-small-cell lung cancer: the Multicenter Italian Lung Cancer in the Elderly Study (MILES) phase III randomized trial.
Journal of the National Cancer Institute 2003;95(5):362-72.
2003: Sabino De Placido; Michele De Laurentiis; Chiara Carlomagno; Ciro Gallo; Francesco Perrone; Stefano Pepe; Angela Ruggiero; Alfredo Marinelli; Caterina Pagliarulo; Luigi Panico; Guido Pettinato; Giuseppe Petrella; Angelo Raffaele Bianco
Twenty-year results of the Naples GUN randomized trial: predictive factors of adjuvant tamoxifen efficacy in early breast cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2003;9(3):1039-46.
2003: Bruno Daniele; Gerardo Rosati; Rosa Tambaro; Alessandro Ottaiano; Ermelinda De Maio; Sandro Pignata; Rosario Vincenzo Iaffaioli; Antonio Rossi; Luigi Manzione; Ciro Gallo; Francesco Perrone
First-line chemotherapy with fluorouracil and folinic acid for advanced colorectal cancer in elderly patients: a phase II study.
Journal of clinical gastroenterology 2003;36(3):228-33.
2003: Bruno Daniele; Ilario De Sio; Francesco Izzo; Gaetano Capuano; Augusto Andreana; Roberto Mazzanti; Antonino Aiello; Paolo Vallone; Francesco Fiore; Giovanni B Gaeta; Francesco Perrone; Sandro Pignata; Ciro Gallo
Hepatic resection and percutaneous ethanol injection as treatments of small hepatocellular carcinoma: a Cancer of the Liver Italian Program (CLIP 08) retrospective case-control study.
Journal of clinical gastroenterology 2003;36(1):63-7.
2002: Cesare Gridelli; Antonio Rossi; Emiddio Barletta; Nicola Panza; Luigi Brancaccio; Riccardo Cioffi; Tonino Pedicini; Giovanni Pietro Ianniello; Elena Piazza; Nestore Rossi; Rosario Vincenzo Iaffaioli; Paolo Maione; Massimo Di Maio; Ciro Gallo; Francesco Perrone
Carboplatin plus vinorelbine plus G-CSF in elderly patients with extensive-stage small-cell lung cancer: a poorly tolerated regimen. Results of a multicentre phase II study.
Lung cancer (Amsterdam, Netherlands) 2002;36(3):327-32.
2002: Francesco Perrone; Ciro Gallo; Bruno Daniele; Giovanni B Gaeta; Francesco Izzo; Gaetano Capuano; Luigi E Adinolfi; Roberto Mazzanti; Fabio Farinati; Silvana Elba; G Piai; M Calandra; Maria Stanzione; Daniele Mattera; A Aiello; Ilario De Sio; F Castiglione; M Russo; Marcello Persico; M Felder; Onofrio G Manghisi; Ermelinda De Maio; Massimo Di Maio; Sandro Pignata
Tamoxifen in the treatment of hepatocellular carcinoma: 5-year results of the CLIP-1 multicentre randomised controlled trial.
Current pharmaceutical design 2002;8(11):1013-9.
2002: Francesco Perrone; Ermelinda De Maio; Paolo Maione; Massimo Di Maio; Alessandro Ottaiano; Matilde Pensabene; Giuseppe Di Lorenzo; Alessandra Vernaglia Lombardi; Ciro Gallo
Survey of modalities of toxicity assessment and reporting in noncomparative prospective studies of chemotherapy in breast cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2002;20(1):52-7.
2001: Cesare Gridelli; Carlo Curcio; Rosario Vincenzo Iaffaioli; Luigi Brancaccio; Modesto D'Aprile; Vittorio Gebbia; Antonio Rossi; Anna Tortoriello; Enzo Veltri; Paolo Maione; A Barbarisi; Ciro Gallo; Cesare Guida; Francesco Perrone
Carboplatin + epirubicin +VP-16 + lenograstim followed by radiotherapy + carboplatin as radiosensitizer in limited small cell lung cancer. A multicenter phase II study.
Anticancer research 2001;21(6A):4179-83.
2001: Cesare Gridelli; Silvio Cigolari; Ciro Gallo; Luigi Manzione; Giovanni Pietro Ianniello; Luciano Frontini; Francesco Ferraù; Sergio Federico Robbiati; Vincenzo Adamo; Giampietro Gasparini; Silvia Novello; Francesco Perrone
Activity and toxicity of gemcitabine and gemcitabine + vinorelbine in advanced non-small-cell lung cancer elderly patients: Phase II data from the Multicenter Italian Lung Cancer in the Elderly Study (MILES) randomized trial.
Lung cancer (Amsterdam, Netherlands) 2001;31(2-3):277-84.
2001: Cesare Gridelli; Luigi Manzione; Francesco Perrone; Enzo Veltri; Riccardo Cioffi; M G Caprio; Luciano Frontini; Antonio Rossi; Emiddio Barletta; ML Barzelloni; Domenico Bilancia; Ciro Gallo
Carboplatin plus paclitaxel in extensive small cell lung cancer: a multicentre phase 2 study.
British journal of cancer 2001;84(1):38-41.
2001: Bruno Daniele; Francesco Perrone; Ciro Gallo; Sandro Pignata; SD De Martino; Rocco De Vivo; Emiddio Barletta; Rosa Tambaro; R Abbiati; Luciano D'Agostino
Oral glutamine in the prevention of fluorouracil induced intestinal toxicity: a double blind, placebo controlled, randomised trial.
Gut 2001;48(1):28-33.
2000: Sabino De Placido; S Tramontana; Ettore Ferrari; Andrea de Matteis; Rossella Lauria; Francesco Perrone; Angelo Raffaele Bianco; Ciro Gallo; Paolo Ricchi; Giuseppe De Placido; Sandro Pignata
Carboplatin, cisplatin and paclitaxel in the treatment of patients with epithelial ovarian cancer.
Anticancer research 2000;20(5C):4023-9.
2000: Cesare Gridelli; Luciano Frontini; Francesco Perrone; Ciro Gallo; M Gulisano; Silvio Cigolari; Federico Castiglione; Sergio Federico Robbiati; Giampietro Gasparini; Giovanni Pietro Ianniello; Antonio Farris; M C Locatelli; R Felletti; Elena Piazza
Gemcitabine plus vinorelbine in advanced non-small cell lung cancer: a phase II study of three different doses. Gem Vin Investigators.
British journal of cancer 2000;83(6):707-14.
2000: Francesco Selvaggi; Antonio Giuliani; Ciro Gallo; Giuseppe Signoriello; Gabriele Riegler; Silvestro Canonico
Randomized, controlled trial to compare the J-pouch and W-pouch configurations for ulcerative colitis in the maturation period.
Diseases of the colon and rectum 2000;43(5):615-20.
1999: Cesare Gridelli; Francesco Perrone; Ciro Gallo; Antonio Rossi; Emiddio Barletta; ML Barzelloni; S Creazzola; Tindaro Gatani; Francesco Fiore; Cesare Guida; Francesco Scognamiglio
Single-agent gemcitabine as second-line treatment in patients with advanced non small cell lung cancer (NSCLC): a phase II trial.
Anticancer research 1999;19(5C):4535-8.
1999: Sabino De Placido; Rossella Lauria; Chiara Carlomagno; Francesco Perrone; Michele De Laurentiis; Ciro Gallo; Angelo Martignetti; T Bellelli; Gennaro Limite; Giuseppe Petrella; Angelo Raffaele Bianco
The impact of schedule on acute toxicity and dose-intensity of high-dose chemotherapy with epirubicin and cyclophosphamide plus colony stimulating factors in advanced breast cancer.
International journal of oncology 1999;15(2):339-46.
1999: Sandro Pignata; Giustina Silvestro; Ettore Ferrari; L Selvaggi; Francesco Perrone; A Maffeo; P Frezza; Giovanni Di Vagno; G Casella; Paolo Ricchi; Gennaro Cormio; Ciro Gallo; Francesco Iodice; F Romeo; R Fiorentino; G Fortuna; S Tramontana
Phase II study of cisplatin and vinorelbine as first-line chemotherapy in patients with carcinoma of the uterine cervix.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1999;17(3):756-60.
1998: Cesare Gridelli; Francesco Perrone; Giovanni Pietro Ianniello; Luigi Brancaccio; Rosario Vincenzo Iaffaioli; Carlo Curcio; Modesto D'Aprile; Riccardo Cioffi; Silvio Cigolari; Antonio Rossi; G Palazzolo; Enzo Veltri; M Pergola; Sabino De Placido; Ciro Gallo; S Monfardini; Angelo Raffaele Bianco
Carboplatin plus vinorelbine, a new well-tolerated and active regimen for the treatment of extensive-stage small-cell lung cancer: a phase II study. Gruppo Oncologico Centro-Sud-Isole.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1998;16(4):1414-9.
1998: Silvestro Canonico; Ciro Gallo; Giuseppe Paolisso; Francesco Pacifico; Giuseppe Signoriello; Guido Sciaudone; Nicola Ferrara; V Piegari; Michele Varricchio; F Rengo
Prevalence of varicose veins in an Italian elderly population.
Angiology 1998;49(2):129-35.
1998: Sandro Pignata; Bruno Daniele; Ciro Gallo; Rocco De Vivo; S Monfardini; Francesco Perrone
Endocrine treatment of hepatocellular carcinoma. Any evidence of benefit?
European journal of cancer (Oxford, England : 1990) 1998;34(1):25-32.
1997: Rosario Maselli; Giuseppe Signoriello; C P de Angelis; I Brancato; A Saturnino; Ciro Gallo
Prevalence of tuberculous infection among students in Naples.
Monaldi archives for chest disease = Archivio Monaldi per le malattie del torace / Fondazione clinica del lavoro, IRCCS [and] Istituto di clinica tisiologica e malattie apparato respiratorio, Università di Napoli, Secondo ateneo 1997;52(4):349-53.
1997: Cesare Gridelli; Francesco Perrone; Ciro Gallo; Filippo De Marinis; Giovanni Pietro Ianniello; Silvio Cigolari; S Cariello; Francesco Di Costanzo; Modesto D'Aprile; Antonio Rossi; R Migliorino; R Bartolucci; Angelo Raffaele Bianco; M Pergola; S Monfardini
Vinorelbine is well tolerated and active in the treatment of elderly patients with advanced non-small cell lung cancer. A two-stage phase II study.
European journal of cancer (Oxford, England : 1990) 1997;33(3):392-7.
1996: Cesare Gridelli; Francesco Perrone; Sergio Palmeri; Modesto D'Aprile; Francesco Cognetti; Antonio Rossi; Vittorio Gebbia; R Pepe; E Veltri; G Airoma; A Russo; P Incoronato; A F Scinto; G Palazzolo; M Natali; Vita Leonardi; Ciro Gallo; Sabino De Placido; Angelo Raffaele Bianco
Mitomycin C plus vindesine plus etoposide (MEV) versus mitomycin C plus vindesine plus cisplatin (MVP) in stage IV non-small-cell lung cancer: A phase III multicentre randomised trial. The "Gruppo Oncologico Centro-Sud-Isole' (G.O.C.S.I.).
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1996;7(8):821-6.